William M. Worrall

Toulouse, 31024, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

A vaccine targeting human IgE induces long-term protection against anaphylaxis in humanized mice.

A vaccine targeting human IgE induces long-term protection against anaphylaxis in humanized mice.

Journal: Science translational medicine
Published: December 03, 2025

An Anti-IL-13 Vaccine Reduces Atopic Dermatitis in Humanized Mice and Induces Neutralizing Antibodies in Nonhuman Primates.

An Anti-IL-13 Vaccine Reduces Atopic Dermatitis in Humanized Mice and Induces Neutralizing Antibodies in Nonhuman Primates.

Journal: Allergy
Published: June 17, 2025

Aging Increases the Severity of Anaphylaxis Through Changes in Mast Cell Numbers and Histamine Sensitivity.

Aging Increases the Severity of Anaphylaxis Through Changes in Mast Cell Numbers and Histamine Sensitivity.

Journal: Allergy
Published: February 26, 2025

Current and future therapeutics targeting mast cells in disease.

Current and future therapeutics targeting mast cells in disease.

Journal: Pharmacology & therapeutics
Published: January 30, 2025

Tissue Distribution and Phenotype of Human Mast Cells in BRGSF and NSG-SGM3-IL15 Humanized Mice.

Tissue Distribution and Phenotype of Human Mast Cells in BRGSF and NSG-SGM3-IL15 Humanized Mice.

Journal: Allergy
Published: October 02, 2024

Conditional neutrophil depletion challenges their contribution to mouse models of anaphylaxis.

Conditional neutrophil depletion challenges their contribution to mouse models of anaphylaxis.

Journal: Allergy
Published: January 24, 2023

The anti-FcεRI antibody MAR-1 depletes basophils and cross-reacts with myeloid cells through its Fc portion.

The anti-FcεRI antibody MAR-1 depletes basophils and cross-reacts with myeloid cells through its Fc portion.

Journal: Allergy
Published: November 02, 2021

Comment on "Tumor-initiating cells establish an IL-33-TGF-β niche signaling loop to promote cancer progression".

Comment on "Tumor-initiating cells establish an IL-33-TGF-β niche signaling loop to promote cancer progression".

Journal: Science (New York, N.Y.)
Published: March 10, 2021
Showing 1-8 of 8

Last Updated: 09/26/2026